OA
AMRI

OFI Advisors’s Albany Molecular Research Inc AMRI Stock Holding History

OFI Advisors’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$142K Sell
8,151
-635
-7% -$12.9K 0.01% 1352
2015
Q2 		$178K Buy
8,786
+576
+7% +$11.1K 0.01% 1302
2015
Q1 		$144K Buy
8,210
+153
+2% +$2.61K 0.01% 1380
2014
Q4 		$131K Buy
8,057
+2,897
+56% +$53.2K 0.01% 1392
2014
Q3 		$114K Sell
5,160
-790
-13% -$16.2K 0.01% 1401
2014
Q2 		$120K Buy
+5,950
New +$101K 0.01% 1391

Other funds holding AMRI

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFI Advisors's AMRI Position: Q3 2015 in Review

OFI Advisors reduced its Albany Molecular Research Inc (AMRI) stake by 7.2% in Q3 2015, selling an estimated $12.9K and leaving 8,151 shares worth $142K. The position accounts for 0.01% of the portfolio, ranked #1352.

OFI Advisors first reported a position in AMRI in Q2 2014 and has held it in 6 quarters since. The position peaked at $178K in Q2 2015. 143 funds tracked by Wall St. Rank hold AMRI as of Q3 2015.

  • OFI Advisors held 8,151 shares of Albany Molecular Research Inc worth $142K as of Q3 2015.
  • OFI Advisors sold 635 Albany Molecular Research Inc shares in Q3 2015, an estimated $12.9K.
  • Albany Molecular Research Inc made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1352 holding.
  • OFI Advisors first reported a position in Albany Molecular Research Inc in Q2 2014 and has held it in 6 quarters since.
  • OFI Advisors's Albany Molecular Research Inc position peaked at $178K in Q2 2015.
  • 143 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.